Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Li, H.; Soria, C.; Griscelli, F.; Opolon, P.; Soria, J.; Yeh, P.; Legrand, C.; Vannier, J.P.; Belin, D.; Perricaudet, M.; Lu, H.
    Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway (2005), Hum. Gene Ther., 16, 1157-1167.
    View publication on PubMed

Application

EC Number Application Comment Organism
3.4.21.73 medicine amino-terminal fragment ATF of urokinase exerts an antitumor effect via dual mechanisms: essentially through targeting the uPA-uPAR system via the EGF-like domain and partially through targeting a uPAR-indepedent interaction via the kringle domain Homo sapiens
3.4.21.73 medicine amino-terminal fragment ATF of urokinase exerts an antitumor effect via dual mechanisms: essentially through targeting the uPA-uPAR system via the EGF-like domain and partially through targeting a uPAR-indepedent interaction via the kringle domain Mus musculus

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.4.21.73 additional information humanized murine ATF, i.e. an amino-terminal fragment of urokinase, represses 79% of membrane-associated enzyme activity on MDA-MB-231 cells, murine ATF represses 29% of activity Homo sapiens
3.4.21.73 additional information humanized murine ATF, i.e. an amino-terminal fragment of urokinase, represses 29% of membrane-associated enzyme activity on LLC cells, murine ATF represses 74% of activity Mus musculus

Organism

EC Number Organism UniProt Comment Textmining
3.4.21.73 Homo sapiens
-
-
-
3.4.21.73 Mus musculus
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
3.4.21.73 LLC cell
-
 Mus musculus
-
3.4.21.73 MDA-MB-231 cell breast cancer cell Homo sapiens
-